Mast cells: New targets for multiple sclerosis therapy?

Journal of Neuroimmunology

Volumn 131, Issue 1-2, 2002, Pages 5-20

  Zappulla, Jacques P ^a,c   Arock, Michel ^b   Mars, Lennart T ^a   Liblau, Roland S ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Faculty of Pharmacy   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Autoimmune disease; Central nervous system; Experimental autoimmune encephalomyelitis; Mast cells; Multiple sclerosis

Indexed keywords

AMLEXANOX; BETA1 INTEGRIN; CD29 ANTIBODY; CHIMERIC PROTEIN; CROMOGLYCATE DISODIUM; CYPROHEPTADINE; CYTOKINE; ESTRIOL; EXOTOXIN; FC RECEPTOR; HISTAMINE AGONIST; HISTAMINE H2 RECEPTOR; HYDROXYZINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; METHYSERGIDE; MONOCLONAL ANTIBODY; MYELIN; PROTEIN BAK; SEX HORMONE; TAMOXIFEN; TESTOSTERONE; TRANILAST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ALLERGIC ENCEPHALOMYELITIS; BLOOD BRAIN BARRIER; CELL FUNCTION; CELL INTERACTION; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DEGRANULATION; DEMYELINATION; DIET; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENCEPHALITIS; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; MAST CELL; METHODOLOGY; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROGNOSIS; PROTECTION; REVIEW; SEX DIFFERENCE; STRESS; T LYMPHOCYTE ACTIVATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; MAST CELLS; MICE; MODELS, IMMUNOLOGICAL; MULTIPLE SCLEROSIS; RATS;

EID: 0036789977     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00250-3     Document Type: Review

References (212)

1. Abbott N.J. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20:2000;131-147.
2. Abraham S.N., Malaviya R. Mast cells in infection and immunity. Infect. Immun. 65:1997;3501-3508.
3. Ackermann L., Pelkonen J., Harvima I.T. Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1. Immunology. 94:1998;247-252.
4. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153:1998;801-813.
5. Ansel J.C., Brown J.R., Payan D.G., Brown M.A. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J. Immunol. 150:1993;4478-4485.
6. Baram D., Vaday G.G., Salamon P., Drucker I., Hershkoviz R., Mekori Y.A. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J. Immunol. 167:2001;4008-4016.
7. Baranzani S.E., Elfstrom C., Chang S.Y., Butunoi C., Murray R., Higuchi R., Oksenberg J.R. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J. Immunol. 165:2000;6576-6582.
8. Bauer O., Razin E. Mast cell-nerve interactions. News Physiol. Sci. 15:2000;213-218.
9. Bebo B.F., Lee C.H., Orr E.L., Linthicum D.S. Mast cell-derived histamine and tumor necrosis factor: differences between SJL/J and BALB/c inbred strains of mice. Immunol. Cell Biol. 74:1996;225-230.
10. Bebo B.F., Yong T., Orr E.L., Linthicum D.S. Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;340-348.
11. Belostotsky R., Lorberboum-Galski H. Apoptosis-inducing human-origin Fcepsilon-Bak chimeric proteins for targeted elimination of mast cells and basophils: a new approach for allergy treatment. J. Immunol. 167:2001;4719-4728.
12. Bidri, M., Vouldoukis, I., Mossalayi, M.D.,Debré, P., Guillosson, J.J., Mazier, D., Arock, M., 1997. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol. 19, 475-783.
13. Bidri M., Feger F., Varadaradjalou S., Ben Hamouda N., Guillosson J.J., Arock, M., 2001. Mast cells as a source and target for nitric oxide. Int. Immunopharmacol. 1, 1543-1558.
14. Bienenstock J., McQueen G., Sestini P., Marshall J.S., Stead R.H., Perdue M.H. Mast cell/nerve interactions in vitro and in vivo. Am. Rev. Respir. Dis. 143:1991;S55-S58.
15. Birk K., Ford C., Smeltzer S., Ryan D., Miller R., Rudick R.A. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch. Neurol. 47:1990;738-742.
16. Bischoff S.C., Sellge G., Lorentz A., Sebald W., Raab R., Manns M.P. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc. Natl. Acad. Sci. U. S. A. 98:1999;8080-8085.
17. Blennerhassett M.G. Nerve and mast cell interaction: cell conflict or information exchange? Prog. Clin. Biol. Res. 390:1994;225-241.
18. Blennerhassett M.G., Tomioka M., Bienenstock J. Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res. 265:1991;121-128.
19. Bo L., Olsson T., Nyland H., Kruger P.G., Taule A., Mork S. Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats. J. Neurol. Sci. 105:1991;135-142.
20. Boven L.A., Montagne L., Nottet H.S., De Groot C.J. Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin. Exp. Immunol. 122:2000;257-263.
21. Bradding P. Human mast cell cytokines. Clin. Exp. Allergy. 26:1996;13-19.
22. Brenner T., Soffer D., Shalit M., Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 122:1994;210-213.
23. Burlina A.P., Ferrari V., Facci L., Skaper S.D., Burlina A.B. Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate. J. Neurochem. 69:1997;1314-1317.
24. Cananzi A.R., Ferro-Milone F., Grigoletto F., Toldo M., Meneghini F., Bortolon F., D'Andrea G. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis. Acta Neurol. Scand. 76:1987;79-85.
25. Carrieri P.B., Provitera V., De Rosa T., Tartaglia G., Gorga F., Perrella O. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 20:1998;373-382.
26. Catto B.A., Lewis F.A., Ottesen E.A. Cercaria-induced histamine release: a factor in the pathogenesis of schistosome dermatitis? Am. J. Trop. Med. Hyg. 5:1980;886-889.
27. Church M.K., Levi-Schaffer F. The human mast cell. J. Allergy Clin. Immunol. 99:1997;155-160.
28. Cocchiara R., Bongiovanni A., Albeggiani G., Azzolina A., Geraci D. Evidence that mast cells can modulate neuroinflammatory responses by tumor necrosis factor-alpha production. NeuroReport. 9:1998;95-98.
29. Cocchiara R., Albeggiani G., Lampiasi N., Bongiovanni A., Azzolina A., Geraci D. Histamine and tumor necrosis factor-alpha production from purified rat brain mast cells mediated by substance P. NeuroReport. 10:1999;575-578.
30. Compton S.J., Cairns J.A., Holgate S.T., Walls A.F. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J. Immunol. 161:1998;1939-1946.
31. Confavreux C., Hutchinson M., Hours M.M., Cornitovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. New Engl. J. Med. 339:1998;285-291.
32. v mice. FASEB J. 12:1998;1693-1700.
33. de Paulis A., Minopoli G., Arbustini E., de Crescenzo G., Dal Piaz F., Pucci P., Russo T., Marone G. Stem cell factor is localized in, released from, and cleaved by human mast cells. J. Immunol. 163:1999;2799-2808.
34. Dery O., Corvera C.U., Steinhoff M., Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274:1998;C1429-C1452.
35. Dietsch G.N., Hinrichs D.J. The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142:1989;1476-1481.
36. Dietsch G.N., Hinrichs D.J. Mast cells proteases liberate encephalitogenic fragments from intact myelin. Cell. Immunol. 135:1991;541-548.
37. Dimitriadou V., Lambracht-Hall M., Reichler J., Theoharides T.C. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience. 39:1990;209-224.
38. Dimitriadou V., Rouleau A., Tuong M.D., Ligneau X., Newlands G.F., Miller H.R., Schwartz J.C., Garbarg M. Rat cerebral mast cells undergo phenotypic changes during development. Brain Res. Dev. Brain Res. 97:1996;29.S-41.S.
39. Dimitriadou V., Rouleau A., Trung Tuong M.D., Newlands G.F., Miller H.R., Luffau G., Schwartz J.C., Garbarg M. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience. 77:1997;829-839.
40. Dimitriadou V., Mécheri S., Koutsilieris M., Fraser W., Al-Daccak R., Mourad W. Expression of functional major histocompatibility complex class II molecules on HMC-I human mast cells. J. Leukoc. Biol. 64:1998;791-799.
41. Dimitriadou V., Pang X., Theoharides T.C. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int. J. Immunopharmacol. 22:2000;673-684.
42. Dines K.C., Powell H.C. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J. Neuropathol. Exp. Neurol. 56:1997;627-640.
43. Drulovic J., Mostarica-Stojkovic M., Levic Z., Stojsavljevic N., Pravica V., Mesaros S. Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 147:1997;145-150.
44. Dvorak A. New aspects of mast cell biology. Int. Arch. Allergy Immunol. 114:1997;1-9.
45. Edvison L., Cervos-Narsson L.I., Owman C.H., Ronnberg A.L. Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain. Neurology. 27:1977;878-883.
46. Ehrlich P. Ueber die spezifischen granulationen des blutes. Arch. Anat. Physiol. Abteil. 1879;571-579.
47. Enerback L. Mast cell heterogeneity: the evolution of the concept of a specific mucosal mast cell. Befus A.D., Bienenstock J., Denburg J.A. Mast Cell Differentiation and Heterogeneity. 1986;1-26 Raven Press, New York.
48. Esposito P., Gheorghe D., Kandere K., Pang X., Connolly R., Jacobson S., Theoharides T.C. Acute stress increases permeability of the blood-brain barrier through activation of brain mast cells. Brain Res. 888:2001;117-127.
49. Fang K.C., Raymond W.W., Lazarus S.C., Caughey G.H. Dog mastocytoma cells secrete a 92-kDa gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97:1996;1589-1596.
50. Feger F., Varadaradjalou S., Gao Z., Abraham S.N., Arock M. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 23:2002;151-158.
51. Finol H.J., Marquez A., Montez de Oca I., Muller B. Skeletal muscle ultrastructural alterations in a case of Guillain-Barré syndrome. Acta Cient. Venez. 42:1991;39-44.
52. Fishman A., Lorberboum-Galski H. Targeted elimination of cells expressing the high-affinity receptor for IgE (Fc epsilon RI) by a Pseudomonas exotoxin-based chimeric protein. Eur. J. Immunol. 27:1997;486-494.
53. Fishman A., Prus D., Belostotsky R., Lorberboum-Galski H. Targeted Fc2′-3-PE40 chimeric protein abolishes passive cutaneous anaphylaxis in mice. Clin. Exp. Immunol. 119:2000;398-403.
54. Flood P.R., Kruger P.G. Fine structure of mast cells in the central nervous system of the hedgehog. Acta Anat. 75:1970;443-452.
55. Fox C.C., Jewell S.D., Whitacre C.C. Rat peritoneal mast cells present antigens to a PPD-specific T cell line. Cell. Immunol. 158:1994;253-264.
56. Frandji P., Oskéritzian C., Cacaraci F., Lapeyre J., Peronet R., David B., Guillet J.G., Mécheri S. Antigen-dependent stimulation by bone-marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151:1993;6318-6328.
57. Friedman M.M., Kaliner M. In situ degranulation of human nasal mucosal mast cells: ultrastructural features and cell-to-cell association. J. Allergy Clin. Immunol. 76:1985;70-82.
58. Gaboury J.P., Johnston B., Niu X.F., Kubes P. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J. Immunol. 154:1995;804-813.
59. Gagari E., Tsai M., Lantz C.S., Fox L.G., Galli S.J. Differential release of mast cell interleukin-6 via c-kit. Blood. 89:1997;2654-2663.
60. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.P., Brunner T., Blasey H., Life P., Talabot D., Flores-Romo L., Thompson J., Kishi K., Butterfield J., Dahinden C., Bonnefoy J.Y. Induction of human IgE synthesis in B-cells by mast cells and basophils. Nature. 365:1993;340-343.
61. Gaytan F., Carrera G., Pinilla L., Aguilar R., Bellido C. Mast cell in the testis, epididymis and accessory glands of the rat: effects of neonatal steroid treatment. J. Androl. 10:1989;351-358.
62. Gaytan F., Bellido C., Carrera G., Aguilar E. Differentiation of mast cells during postnatal development of neonatally estrogen-treated rats. Cell Tissue Res. 259:1990;25-31.
63. Goetzl E.J., Chernov T., Renold F., Payan D.G. Neuropeptide regulation of the expression of immediate hypersensitivity. J. Immunol. 135:1985;802s-805s.
64. Goldschmidt R.C., Hough L.B., Glick S.D., Padawer J. Mast cells in the rat thalamus: nuclear localization, sex differences, and left-right asymmetry. Brain Res. 323:1984;209-217.
65. Goldschmidt R.C., Hough L.B., Glick S.D. Rat brain mast cells: contribution to brain histamine levels. J. Neurochem. 44:1985;1943-1947.
66. Goodin D.S., Ebers G.C., Johnson K.P., Rodriguez M., Sibley W.A., Wolinsky J.S. The relationship of MS to physical trauma and psychological stress. Neurology. 52:1999;1737-1745.
67. Greenwood J. Mechanisms of blood-brain barrier breakdown. Neuroradiology. 33:1991;95-100.
68. Gruber B.L., Marchese M.L., Kew R.R. Transforming growth factor-beta 1 mediates mast cell chemotaxis. J. Immunol. 152:1994;5860-5867.
69. Hart P.H. Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell Biol. 79:2001;149-153.
70. He S., Peng Q., Walls A.F. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J. Immunol. 159:1997;6216-6225.
71. Hebert-Katz E. The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis. Ann. N.Y. Acad. Sci. 756:1995;283-293.
72. Ibrahim M.Z.M. Mast cells in the mammalian nervous system: part 1. Morphology, distribution and histochemistry. J. Neurol. Sci. 21:1974;431-478.
73. Ibrahim M.Z., Reder T., Lawand R., Takash W., Sallouh-Khatib S. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70:1996;131-138.
74. Ibrahim S.M., Mix E., Böttcher T., Koczan D., Gold R., Rolfs A., Thiesen H.J. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain. 124:2001;1927-1938.
75. Imamura T., Dubin A., Moore W., Tanaka R., Travis J. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab. Invest. 74:1996;861-870.
76. Jaiswal K., Krishna A. Effects of hormones on the number, distribution and degranulation of mast cells in the ovarian complex of mice. Acta Physiol. Hung. 84:1996;183-190.
77. Johnson D., Seeldrayers P., Weiner H.L. The role of mast cells in demyelination: 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 444:1988;195-198.
78. Johnson D., Yasui D., Seeldrayers P. An analysis of mast cell frequency in the rodent nervous system: numbers vary between different strains and can be reconstituted in mast cell-deficient mice. J. Neuropathol. Exp. Neurol. 50:1991;227-234.
79. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A.R., Malolepszy J., Zak-Nejmark T., Koga R., Kobayashi T., Blaser K., Akdis C.A. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature. 413:2001;420-425.
80. Kambe N., Kambe M., Kochan J.P., Schwartz L.B. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood. 97:2001;2045-2052.
81. Kanbe N., Tanaka A., Kanbe M., Itakura A., Kurosawa M., Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29:1999;2645-2649.
82. Kaplan A.P. Chemokines, chemokine receptors and allergy. Int. Arch. Allergy Immunol. 124:2001;423-431.
83. Karimi K., Redegeld F.A., Blom R., Nijkamp F.P. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp. Hematol. 28:2000;626-634.
84. Kermode A.G., Thompson A.J., Tofts P., MacManus D.G., Kendall B.E., Kingsley D.P., Moseley I.F., Rudge P., McDonald W.I. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain. 113:1990;1477-1489.
85. Kirshenbaum A.S., Goff J.P., Semere T., Foster B., Scott L.M., Metcalfe D.D. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood. 94:1999;2333-2342.
86. Korn-Lubetzki I., Kahana E., Cooper G., Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann. Neurol. 16:1984;229-231.
87. Krishnaswamy G., Kelley J., Johson D., Youngberg G., Stone W., Huang S.K., Bieber J., Chi D.S. The human mast cell: functions in physiology and disease. Front. Biosci. 6:2001;D1109-D1127.
88. Krüger P.G. Mast cells and multiple sclerosis: a quantitative analysis. Neuropathol. Appl. Neurobiol. 27:2001;275-280.
89. Krüger P.G., Nyland H.I. The role of mast cells and diet in the onset and maintenance of multiple sclerosis: a hypothesis. Med. Hypotheses. 44:1995;66-69.
90. Krüger P.G., Bo L., Myhr K.M., Karlsen A.E., Taule A., Nyland H.I., Mork S. Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol. Scand. 81:1990;31-36.
91. Kubes P., Granger D.N. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc. Res. 32:1996;699-708.
92. Kubes P., Kanwar S. Histamine induces leukocyte rolling in postcapillary venules. A P-selectin mediated event. J. Immunol. 152:1994;3570-3577.
93. Kubes P., Ward P.A. Leukocyte recruitment and the acute inflammatory response. Brain Pathol. 10:2000;127-135.
94. Kubes P., Kanwar S., Niu X.F., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
95. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:1997;307-312.
96. Lambracht-Hall M., Dimitriadou V., Theoharides T.C. Migration of mast cells in the developing rat brain. Dev. Brain Res. 56:1990;151-159.
97. Landiero L.B., Aloe L., Levi-Montalcini R., Buttinelli C., Schilter D., Gillessen S., Otten U. Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci. Lett. 147:1992;9-12.
98. Lauer K. Diet and multiple sclerosis. Neurology. 49:1997;S55-S61.
99. Lees M., Taylor D.J., Wooley D.E. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur. J. Biochem. 223:1994;171-177.
100. Legler D.F., Loetscher M., Jones S.A., Dahinden C.A., Arock M., Moser B. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur. J. Immunol. 26:1996;753-758.
101. Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L., Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3739-3743.
102. Letourneau R., Pang X., Sant G.R., Theoharides T.C. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br. J. Urol. 77:1996;41-54.
103. Levi-Schaffer F., Shalit M. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. Int. Arch. Allergy Appl. Immunol. 90:1989;352-357.
104. Levi-Schaffer F., Riesel N., Soffer D., Abramsky O., Brenner T. Mast cell activity in experimental allergic encephalomyelitis. Mol. Chem. Neuropathol. 15:1991;173-184.
105. Ley K. Histamine can induce leukocyte rolling in rat mesenteric venules. Am. J. Physiol. 267:1994;H1017-H1023.
106. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiol. Res. 32:1996;733-742.
107. Lindner J.R., Kahn M.L., Coughlin S.R., Sambrano G.R., Schauble E., Bernstein D., Foy D., Hazefi-Moghabam A., Ley K. Delayed onset of inflammation in protease-activated-2-deficient mice. J. Immunol. 165:2000;6504-6510.
108. Linthicum D.S. Development of acute experimental autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease. Immunobiology. 162:1982;220-221.
109. Lohi J., Harvima I., Keski-Oja J. Pericellular substrates of human cell tryptase: 72,000 gelatinase and fibronectin. J. Cell. Biochem. 50:1992;337-349.
110. MacDonald S.M., Mezei M., Mezei C. Effect of Wallerian degeneration on histamine concentration in peripheral nerve. J. Neurochem. 36:1981;9-16.
111. Malaviya R., Twesten N.J., Ross E.A., Abraham S.N., Pfeifer J.D. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156:1996;1490-1496.
112. Manni L., Micera A., Pistillo L., Aloe L. Neonatal handling in EAE-susceptible rats alters NGF levels and mast cell distribution in the brain. Int. J. Dev. Neurosci. 16:1998;1-8.
113. Marshall J.L., Gauldie J., Nielsen L., Bienenstock J. Leukemia inhibitory factor production by mast cells. Eur. J. Immunol. 23:1993;2116-2120.
114. Mayhan W.G. Leukocyte adherence contributes to disruption of the blood-brain barrier during activation of mast cells. Brain Res. 869:2001;112-120.
115. Mayrhofer G. Thymus-dependent and thymus-independent subpopulations of intestinal intraepithelial lymphocytes: a granular subpopulation of probable bone marrow origin and relationship to mucosal mast cells. Blood. 55:1980;532-535.
116. McCloskey M.A. Cholera toxin potentiates IgE-coupled inositol phospholipid hydrolysis and mediator secretion by RBL-2H3 cells. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7260-7264.
117. McLachlan J.B., Abraham S.N. Studies of the multifaceted mast cell response to bacteria. Curr. Opin. Microbiol. 4:2001;260-266.
118. Meininger C.J., Yano H., Rottapel R., Bernstein A., Zsebo K.M., Zetter B.R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood. 79:1992;958-963.
119. Mekori Y.A., Metcalfe D.D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104:1999;517-523.
120. Mekori Y.A., Metcalfe D.D. Mast cells and innate immunity. Immunol. Rev. 173:2000;131-140.
121. Menendez-Pelaez A., Mayo J.C., Sainz R.M., Perez M., Antolin I., Tolivia D. Development and hormonal regulation of mast cells in the Harderian gland of Syrian hamsters. Anat. Embryol. 186:1992;91-97.
122. Meng H., Tonnesen M.G., Marchese M.J., Clark R.A., Bahou W.F., Gruber B.L. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J. Cell. Physiol. 165:1995;40-53.
123. Metcalfe D.D., Bram D., Mekori Y.A. Mast cells. Physiol. Rev. 77:1997;1033-1079.
124. Middel P., Thelen P., Blaschke S., Polzien F., Reich K., Blaschke V., Wrede A., Hummel K.M., Gunawan B., Radzun H.J. Expression of the T-cell chemoattractant lymphotactin in Crohn's disease. Am. J. Pathol. 159:2001;1751-1761.
125. Middel P., Reich K., Polzien F., Blaschke V., Hemmerlein B., Herms J., Korabiowska M., Radzun H.J. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease. Gut. 49:2001;795-803.
126. Middleton E. Jr., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52:2000;673-751.
127. Modat G., Benmbareck A., Lalaurie M. Quantitative variations in the number and size of peritoneal mastocytes in the female rat during the normal sexual cycle, following ovariectomy and administration of estrogens. C.R. Seances Soc. Biol. Fil. 176:1982;675-680.
128. Mohr D.C., Goodkin D.E., Bacchetti P., Boudewyn A.C., Huang L., Marrietta P., Cheuk W., Dee B. Psychological stress and the subsequent appearances of new brain MRI lesions in MS. Neurology. 55:2000;55-61.
129. Molino M., Barnathan E.S., Numerof R., Clark J., Dreyer M., Cumashi A., Hoxie J.A., Schechter N., Woolkalis M., Brass L.F. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272:1997;4043-4049.
130. Naukkarinen A., Harvima I., Paukkonen K., Aalto M.L., Horsmanheimo M. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch. Dermatol. Res. 185:1993;341-346.
131. Nelson R.B., Siman R., Iqbal M.A., Potter H. Identification of a chymotrypsin-like mast cell protease in rat brain capable of generating the N-terminus of the Alzheimer amyloid beta-protein. J. Neurochem. 61:1993;567-577.
132. Nennesmo I., Reinholt F. Mast cells in nerve and neuromas of mice. Neurosci. Lett. 69:1986;296-301.
133. Neuman J. Über das Vorkommen der sogenannten 'Mastzellen' bei pathologischen Veränderungen des Gehirns. Virchows Arch. Pathol. Anat. 122:1890;378-380.
134. Newson B., Dahlstrom A., Enerback L., Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience. 10:1983;565-570.
135. Olsson Y. Mast cells in the nervous system. Int. Rev. Cytol. 24:1968;27-70.
136. Olsson Y. Mast cells in plaques of multiple sclerosis. Acta Neurol. Scand. 50:1974;611-618.
137. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268.
138. Orr E.L., Stanley N.C. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis. J. Neurochem. 53:1989;111-118.
139. Osipchuk Y., Cahalan M. Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature. 359:1992;241-244.
140. Ottosson A., Edvinsson L. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia. 17:1997;166-174.
141. Pang X., Cotreau-Bibbo M.M., Sant G.R., Theoharides T.C. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br. J. Urol. 75:1995;154-161.
142. Pang X., Letourneau R., Rozniecki J.J., Wang L., Theoharides T.C. Definitive characterization of rat hypothalamic mast cells. Neuroscience. 73:1996;889-902.
143. Payan D.G., Levine J.D., Goetzl E.J. Modulation of immunity and hypersensitivity by sensory neuropeptides. J. Immunol. 132:1984;1601-1604.
144. Payne A.P., McGadey J., Johnston H.S., Moore M.R., Thompson G.G. Mast cells in the hamster harderian gland: sex differences, hormonal control and relationship to porphyrin. J. Anat. 135:1982;451-461.
145. Pedotti R., Mitchell D., Wedemeyer J., Karpuj M., Chabas D., Hattab E.M., Tsai M., Galli S.J., Steinman L. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2:2001;216-222.
146. Poncet P., Arock M., David B. MHC class II-dependent activation of CD4+T cell hybridomas by human mast cells through superantigen presentation. J. Leukoc. Biol. 66:1999;105-112.
147. Powell H.C., Costello M.L., Myers R.R. Galactose neuropathy. Permeability studies, mechanism of edema, and mast cell abnormalities. Acta Neuropathol. (Berl.). 55:1981;89-95.
148. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
149. Prodeus A.P., Zhou X., Maurer M., Galli S.J., Carroll M.C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature. 390:1997;172-175.
150. Purcell W.M., Atterwill C.K. Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochem. Res. 20:1995;521-532.
151. Rentzos M., Nikolaou C., Rombos A., Voumvourakis K., Segditsa I., Papageorgiou C. Tumor necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies. J. Neurol. 243:1996;165-170.
152. Rouleau A., Dimitriadou V., Trung Tuong M.D., Newlands G.F., Miller H.R., Schwartz J.C., Garbarg M. Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis. J. Neural Transm. 104:1997;399-417.
153. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37:1995;63-66.
154. Rozniecki J.J., Dimitriadou V., Lambracht-Hall M., Pang X., Theoharides T.C. Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res. 849:1999;1-15.
155. Ruitenberg E.J., Elgersma A. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature. 264:1976;258-260.
156. Rumsaeng V., Vliagoftis H., Oh C.K., Metcalfe D.D. Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A. J. Immunol. 158:1997;1353-1360.
157. Rumsaeng V., Cruikshank W.W., Foster B., Prussin C., Kirshenbaum A.S., Davis T.A., Kornfeld H., Center D.M., Metcalfe D.D. Human mast cells produce the CD4+T lymphocyte chemoattractant factor, IL-16. J. Immunol. 159:1997;2904-2910.
158. Sawada J., Itakura A., Tanaka A., Furusaka T., Matsuda H. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood. 95:2000;2052-2058.
159. Secor V.H., Secor W.E., Gutekunst C.A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191:2000;813-821.
160. Seeldrayers P.A., Levin L.A., Johnson D. Astrocytes support mast cell viability in vitro. J. Neuroimmunol. 36:1992;239-243.
161. Shalit M., Brenner T., Shohami E., Levi-Schaffer F. Interaction between mast cells and glial cells: an in vitro study. J. Neuroimmunol. 43:1993;195-199.
162. Shanas U., Bhasin R., Sutherland A.K., Silverman A.J., Silver R. Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J. Neuroimmunol. 90:1998;207-211.
163. Sharief M.K., Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. New Engl. J. Med. 325:1991;467-472.
164. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J. Neuroimmunol. 43:1993;15-22.
165. Shirama K., Kohda M., Kohano M. Effects of endocrine glands and hormone replacement on mast cell count of the harderian gland in mice. Acta Anat. 131:1988;327-331.
166. Shishimori Y., Oyama Y., Matsushita O., Yamashita K., Furuichi H., Okabe A., Maeta H., Hata Y., Kobayashi R. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind S100A12 and S100A13 of the S100 protein family. Biochem. J. 338:1999;583-589.
167. Silber G., Proud D., Warner J., Naclerio R., Kagey-Sobotka A., Lichtenstein L., Eggleston P. In vivo release of inflammatory mediators by hyperosmolar solutions. Am. Rev. Respir. Dis. 137:1988;606-612.
168. Silver R., Silverman A.J., Vitkovic L., Lederhendler I.I. Mast cells in the brain: evidence and functional significance. Trends Neurol. Sci. 19:1996;25-31.
169. Silverman A.J., Sutherland A.K., Wilhelm M., Silver R. Mast cells migrate from the blood to brain. J. Neurosci. 20:2000;401-408.
170. Singh L.K., Boucher W., Pang X., Letourneau R., Seretakis D., Green M., Theoharides T.C. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J. Pharmacol. Exp. Ther. 288:1999;1349-1356.
171. Skaper S.D., Facci L., Romanello S., Leon A. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J. Neurochem. 66:1996;1157-1166.
172. Skaper S.D., Facci L., Kee W.J., Strijbos P.J. Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells. J. Neurochem. 76:2001;47-55.
173. Skokos D., Le Panse S., Villa I., Rouselle J.C., Peronet R., David B., Namane A., Mécheri S. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J. Immunol. 166:2001;868-876.
174. Skokos D., Le Panse S., Villa I., Rouselle J.C., Peronet R., Namane A., David B., Mécheri S. Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes. Int. Arch. Allergy Immunol. 124:2001;133-136.
175. Skotfitsch G., Savitt J.M., Jacobowitz D.M. Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery. Histochemistry. 82:1985;5-8.
176. Smith T.J., Weis J.H. Mucosal T cells and mast cells share common adhesion molecules. Immunol. Today. 17:1996;60-63.
177. Sperr W.R., Bankl H.C., Mundigler G., Klappacher G., Grosschimdt K., Agis H., Simon P., Laufer P., Imhof M., Radaszkiewicz T. The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood. 84:1994;3876-3884.
178. Stanley N.C., Jackson F.L., Orr E.L. Attenuation of experimental autoimmune encephalomyelitis by compound 48/80 in Lewis rats. J. Neuroimmunol. 29:1990;223-228.
179. Stead R.H., Kosecka-Janiszewska U., Oestreicher A.B., Dixon M.F., Bienenstock J. Remodeling of B-50 (GAP-43)- and NSE-immunoreactive mucosal nerves in the intestines of rats infected with Nippostrongylus brasiliensis. J. Neurosci. 11:1991;3809-3821.
180. Sugama Y., Malik A.B. Thrombin receptor 14-amino acid peptide mediates endothelial hyperadhesivity and neutrophil adhesion by P-selectin-dependent mechanism. Circ. Res. 71:1992;1015-1019.
181. Tanaka A., Arai K., Kitamura Y., Matsuda H. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood. 94:1999;2390-2395.
182. Tedla N., Wang H.W., McNeil H.P., Di Girolamo N., Hampartzoumian T., Wakefield D., Lloyd A. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. J. Immunol. 161:1998;5663-5672.
183. Theoharides T.C. Mast cells: the immune gate to the brain. Life Sci. 46:1990;607-617.
184. Theoharides T.C. The mast cell: a neuroimmunoendocrine master player. Int. J. Tissue React. 18:1996;1-21.
185. Theoharides T.C. Mast cells and stress. A psychoneuroimmunological perspective. J. Clin. Psychopharmacol. 22:2002;103-108.
186. Theoharides T.C., Bondy P.K., Tsakalos N.D., Askenase P.W. Differential release of serotonin and histamine from mast cells. Nature. 297:1982;229-231.
187. Theoharides T.C., Dimitriadou V., Letourneau R., Rozniecki J.J., Vliagoftis H., Boucher W. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience. 57:1993;861-871.
188. Theoharides T.C., Spanos C., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J.J., Webster E., Chrousos G.P. Stress-induced intracranial mast cells degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology. 136:1995;5745-5750.
189. Thorlacius H., Raud J., Rosengren-Beezley S., Forrest M.J., Hedqvist P., Lindbom L. Mast cell activation induces P-selectin-dependent leukocyte rolling and adhesion in postcapillary venules in vivo. Biochem. Biophys. Res. Commun. 203:1994;1043-1049.
190. Tkaczyk C., Frandji P., Botros H.G., Poncet P., Lapeyre J., Peronet R., David B., Mécheri S. Mouse bone marrow-derived mast cells and mast cells lines constitutively produce B cell growth and differentiation activities. J. Immunol. 157:1996;1720-1728.
191. Tkaczyk C., Villa I.J., Peronet R., David B., Chouaib S., Mécheri S. In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation. J. Allergy Clin. Immunol. 105:2000;134-142.
192. Toms R., Weiner H.L., Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30:1990;169-177.
193. Tromp S.C., Tangelder G.J., Slaaf D.W., Reneman R.S., van Velzen S., Engels W., van Breda E., oude Egbrink M.G.A. The role of mast cells and histamine in leukocyte-endothelium interactions in four rat strains. Pflügers Arch. 436:1998;255-261.
194. Tsukuda N., Matsuda M., Miyagi K., Yangisawa N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology. 43:1993;2679-2682.
195. Tuomisto L., Kilpeläinen H., Riekkinen P. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions. 13:1983;255-257.
196. Villa I., Skokos D., Tkaczyk C., Peronet R., David B., Huerre M., Mecheri S. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology. 102:2001;165-172.
197. Vliagoftis H., Dimitriadou V., Theoharides T.C. Progesterone triggers selective mast cell secretion of 5-hydroxytryptamine. Int. Arch. Allergy Appl. Immunol. 93:1990;113-119.
198. Vliagoftis H., Dimitriadou V., Boucher W., Rozniecki J.J., Correia I., Raam S., Theoharides T.C. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int. Arch. Allergy Appl. Immunol. 98:1992;398-409.
199. Voskuhl R.R., Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist. 7:2001;258-270.
200. Wang H.W., Tedla N., Lloyd A.R., Wakefield D., McNeil H.P. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102:1998;1617-1626.
201. Waxman F., Taguiam J., Whitacre C. Modification of the clinical and hispotathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine. Cell. Immunol. 85:1984;82-93.
202. Weber J.R., Angstwurm K., Rosenkranz T., Lindauer U., Burger W., Einhaupl K.M., Dimagl U. Histamine (H1) receptor antagonist inhibits leukocyte rolling in pial vessels in the early phase of bacterial meningitis in rats. Neurosci. Lett. 226:1997;17-20.
203. Wedemeyer J., Tsai M., Galli S.J. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12:2000;624-631.
204. Weinshenker B.G. Epidemiology of multiple sclerosis. Neurol. Clin. 14:1996;291-308.
205. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol. 61:1997;233-245.
206. Yamaki K., Thorlacius H., Xie X., Lindbom L., Hedqvist P., Raud J. Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br. J. Pharmacol. 123:1998;390-399.
207. Yamamura H., Nabe T., Kohno S., Ohata K. Endothelin-1 induces release of histamine and leukotriene C4 from mouse bone marrow-derived mast cells. Eur. J. Pharmacol. 257:1994;235-242.
208. Yong T., Zheng M.Q., Linthicum D.S. Local histamine release increases leukocyte rolling in the cerebral microcirculation of the mouse. Brain Inj. 11:1997;765-774.
209. Zhang S.C., Fedoroff S. Cellular localization of stem cell factor and c-kit receptor in the mouse nervous system. J. Neurosci. Res. 47:1997;1-15.
210. Zhao X.J., McKerr G., Dong Z., Higgins C.A., Carson J., Yang Z.Q., Hannigan B.M. Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax. 56:2001;205-211.
211. Zhuang X., Silverman A.J., Silver R. Brain mast cell degranulation regulates blood-brain barrier. J. Neurobiol. 31:1996;393-403.
212. Zimmerman B.J., Paulson J.C., Arrhenius T.S., Gaeta F.C., Granger D.N. Thrombin receptor peptide-mediated leucocyte rolling in rat mesenteric venules: roles of P-selectin and sialyl Lewis X. Am. J. Physiol. 267:1994;H1049-H1053.